Capitolis Liquid Global Markets’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$339M Buy
368,169
+102,870
+39% +$104M 2.15% 12
2025
Q4
$285M Sell
265,299
-88,801
-25% -$84.9M 1.7% 11
2025
Q3
$270M Sell
354,100
-13,100
-4% -$9.75M 2.16% 10
2025
Q2
$286M Buy
367,200
+15,700
+4% +$12.2M 2.1% 12
2025
Q1
$290M Sell
351,500
-82,400
-19% -$68.6M 2.57% 10
2024
Q4
$335M Sell
433,900
-46,500
-10% -$38.5M 3.26% 9
2024
Q3
$426M Buy
480,400
+266,700
+125% +$240M 4.52% 6
2024
Q2
$193M Buy
213,700
+102,300
+92% +$81.8M 2.39% 10
2024
Q1
$86.7M Buy
+111,400
New +$79.3M 1.39% 27

Other funds holding LLY

Capitolis Liquid Global Markets's LLY Position: Q1 2026 in Review

Capitolis Liquid Global Markets increased its Eli Lilly (LLY) stake by 39% in Q1 2026, buying an estimated $104M and bringing the position to 368,169 shares worth $339M. The position accounts for 2.15% of the portfolio, ranked #12.

Capitolis Liquid Global Markets first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $426M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Capitolis Liquid Global Markets held 368,169 shares of Eli Lilly worth $339M as of Q1 2026.
  • Capitolis Liquid Global Markets bought 102,870 Eli Lilly shares in Q1 2026, an estimated $104M.
  • Eli Lilly made up 2.15% of Capitolis Liquid Global Markets's portfolio in Q1 2026, its #12 holding.
  • Capitolis Liquid Global Markets first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • Capitolis Liquid Global Markets's Eli Lilly position peaked at $426M in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q1 2026, filed 15 May 2026.